These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 34178927)
21. [Fecal microbiota transplantation: from the evidence to the realty of the field]. Ballif A; Gerber S; Carrez L; Audry M; Sadeghipour F; Mitouassiwou A; Croxatto A; Opota O; Prod'hom G; Henchoz S; Schoepfer A; Cavassini M; Galpérine T Rev Med Suisse; 2021 Apr; 17(734):726-731. PubMed ID: 33852207 [TBL] [Abstract][Full Text] [Related]
22. Validation of Lyophilized Human Fecal Microbiota for the Treatment of Yamada CH; Ortis GB; Buso GM; Martins TC; Zequinao T; Telles JP; Wollmann LC; Montenegro CO; Dantas LR; Cruz JW; Tuon FF Microorganisms; 2024 Aug; 12(8):. PubMed ID: 39203583 [TBL] [Abstract][Full Text] [Related]
23. Fecal Microbiota Transplant in Severe and Non-Severe Popa D; Neamtu B; Mihalache M; Boicean A; Banciu A; Banciu DD; Moga DFC; Birlutiu V J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945118 [TBL] [Abstract][Full Text] [Related]
24. Fecal microbiota-based treatment for recurrent Clostridioides difficile infection. Walter J; Shanahan F Cell; 2023 Mar; 186(6):1087. PubMed ID: 36931236 [TBL] [Abstract][Full Text] [Related]
25. Cutting edges in Clostridioides difficile infections. Durovic A; Tschudin-Sutter S Swiss Med Wkly; 2021 Sep; 151():w30033. PubMed ID: 34652093 [TBL] [Abstract][Full Text] [Related]
26. Fecal microbiota transplantation for recurrent Clostridioides difficile infection. Haber SL; Raney CRK; Larson TL; Lau JP Am J Health Syst Pharm; 2019 Jun; 76(13):935-942. PubMed ID: 31361890 [TBL] [Abstract][Full Text] [Related]
27. Fecal Transplants by Colonoscopy and Capsules Are Cost-Effective Strategies for Treating Recurrent Clostridioides difficile Infection. Luo Y; Lucas AL; Grinspan AM Dig Dis Sci; 2020 Apr; 65(4):1125-1133. PubMed ID: 31493042 [TBL] [Abstract][Full Text] [Related]
29. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI. Finn E; Andersson FL; Madin-Warburton M BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040 [TBL] [Abstract][Full Text] [Related]
30. Clostridioides difficile infection in US hospitals: a national inpatient sample study. Ramai D; Dang-Ho KP; Lewis C; Fields PJ; Ofosu A; Barakat M; Aamar A; Ofori E; Lai J; Lanke G; Dhaliwal A; Reddy M; Gasperino J Int J Colorectal Dis; 2020 Oct; 35(10):1929-1935. PubMed ID: 32556651 [TBL] [Abstract][Full Text] [Related]
31. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure. Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961 [TBL] [Abstract][Full Text] [Related]
32. Advancing therapeutics for recurrent clostridioides difficile infections: an overview of vowst's FDA approval and implications. Jain N; Umar TP; Fahner AF; Gibietis V Gut Microbes; 2023; 15(1):2232137. PubMed ID: 37431860 [TBL] [Abstract][Full Text] [Related]
33. Prevention and treatment of recurrent Clostridioides difficile infection. Shin JH; Warren CA Curr Opin Infect Dis; 2019 Oct; 32(5):482-489. PubMed ID: 31369420 [TBL] [Abstract][Full Text] [Related]
34. Randomised clinical trial: a 12-strain bacterial mixture versus faecal microbiota transplantation versus vancomycin for recurrent Clostridioides difficile infections. Rode AA; Chehri M; Krogsgaard LR; Heno KK; Svendsen AT; Ribberholt I; Helms M; Engberg J; Schønning K; Tvede M; Andersen CØ; Jensen US; Petersen AM; Bytzer P Aliment Pharmacol Ther; 2021 May; 53(9):999-1009. PubMed ID: 33694229 [TBL] [Abstract][Full Text] [Related]
35. Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection. Normington C; Moura IB; Bryant JA; Ewin DJ; Clark EV; Kettle MJ; Harris HC; Spittal W; Davis G; Henn MR; Ford CB; Wilcox MH; Buckley AM NPJ Biofilms Microbiomes; 2021 Feb; 7(1):16. PubMed ID: 33547298 [TBL] [Abstract][Full Text] [Related]
36. Application of Microbiome Management in Therapy for Chiu CW; Tsai PJ; Lee CC; Ko WC; Hung YP Pathogens; 2021 May; 10(6):. PubMed ID: 34073695 [TBL] [Abstract][Full Text] [Related]
37. Fecal microbiota transplantation in a toddler after heart transplant was a safe and effective treatment for recurrent Clostridiodes difficile infection: A case report. Spinner JA; Bocchini CE; Luna RA; Thapa S; Balderas MA; Denfield SW; Dreyer WJ; Nagy-Szakal D; Ihekweazu FD; Versalovic J; Savidge T; Kellermayer R Pediatr Transplant; 2020 Feb; 24(1):e13598. PubMed ID: 31617299 [TBL] [Abstract][Full Text] [Related]